| Product Name |
Recombinant Human LY86 Protein |
| Product Overview |
This recombinant human LY86 protein includes amino acids 21-162aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id |
O95711 |
| Recommended Name |
Lymphocyte antigen 86 |
| Gene Name |
LY86 |
| Synonyms |
Lymphocyte antigen 86, lymphocyte antigen 86, dJ80N2.1, MD-1, MMD-1, RP1-80N2.1 |
| Species |
Human |
| Predicted Molecular Mass |
18.1 kDa |
| Expression System |
E.coli |
| Expression Range |
21-162aa |
| Tag |
N-6His |
| Purity |
>95% |
| Formulation |
Lyophilized |
| Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area |
Immunology |
| Target Function |
May cooperate with CD180 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) and cytokine production. Important for efficient CD180 cell surface expression. |
| Subcellular Location |
Secreted, extracellular space. Note=Associated with CD180 at the cell surface. |
| Tissue Specificity |
Highly expressed in B-cells, monocytes and tonsil. |
